You have 9 free searches left this month | for more free features.

Untreated High Risk Follicular Lymphoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Follicular Lymphoma, Lymphoma, Follicular Trial in United States (Zevalin Therapeutic Regimen, R-CVP)

Terminated
  • Follicular Lymphoma
  • Lymphoma, Follicular
  • Zevalin Therapeutic Regimen
  • R-CVP
  • Jacksonville, Florida
  • +5 more
Dec 16, 2021

Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)

Not yet recruiting
  • Follicular Lymphoma
  • Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Oct 30, 2023

Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)

Recruiting
  • Follicular Lymphoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Follicular Lymphoma Trial in New York (Mosunetuzumab, Tazemetostat Pill)

Not yet recruiting
  • Follicular Lymphoma
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Aug 8, 2023

Obinutuzumab-based Therapy for Previously Untreated FL

Recruiting
  • Follicular Lymphoma
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 3, 2023

Follicular Lymphoma Trial in Houston (Bendamustine, Mitoxantrone, Rituximab)

Terminated
  • Follicular Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 1, 2020

Lymphoma, Follicular, Follicular Lymphoma Trial in Saint Louis (Mosunetuzumab, Polatuzumab vedotin)

Recruiting
  • Lymphoma, Follicular
  • Follicular Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 14, 2022

Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma Trial in

Recruiting
  • Ann Arbor Stage II Follicular Lymphoma
  • +5 more
  • Fresno, California
  • +2 more
Jan 24, 2023

Follicular Lymphoma (FL) Trial in Noblesville (Odronextamab, Rituximab, Cyclophosphamide)

Recruiting
  • Follicular Lymphoma (FL)
  • Noblesville, Indiana
    Investigative Clinical Research of Indiana
Oct 18, 2023

Mantle Cell Lymphoma Trial in Houston (Ibrutinib)

Recruiting
  • Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Nov 1, 2022

Follicular Lymphoma Trial in Duarte, Irvine (procedure, other, biological, drug)

Not yet recruiting
  • Follicular Lymphoma
  • Biospecimen Collection
  • +7 more
  • Duarte, California
  • +1 more
Oct 27, 2023

Peripheral T Cell Lymphoma, Epigenetic Repression Trial in Tianjin (Chidamide, Azacitidine)

Recruiting
  • Peripheral T Cell Lymphoma
  • Epigenetic Repression
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 14, 2023

Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype Trial in Guangzhou (Chidamide combined with CHOP,

Recruiting
  • Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
  • Guangzhou, Guangdong, China
    Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University
Oct 7, 2022

Follicular Lymphoma (FL) Trial in Westbury (Odronextamab, Rituximab, Cyclophosphamide)

Recruiting
  • Follicular Lymphoma (FL)
  • Westbury, New York
    Clinical Research Alliance Inc
Oct 13, 2023

Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann

Active, not recruiting
  • Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
  • +11 more
  • Washington, District of Columbia
  • +6 more
Feb 2, 2023

Lymphoma, Mantle Cell Lymphoma Trial in Houston (Acalabrutinib, Rituximab, Brexucabtagene Autoleucel)

Not yet recruiting
  • Lymphoma
  • Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1

Active, not recruiting
  • Ann Arbor Stage I Grade 1 Follicular Lymphoma
  • +9 more
  • Quality-of-Life Assessment
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 3, 2022

Ann Arbor Stage II Grade 1 Follicular Lymphoma, Ann Arbor Stage II Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 1

Active, not recruiting
  • Ann Arbor Stage II Grade 1 Follicular Lymphoma
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 18, 2022

Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,

Completed
  • Non-Hodgkin's Lymphoma
  • Etoposide, carboplatin, ifosfamide
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 23, 2022

Follicular Lymphoma Trial (Bendamustine, Rituximab, Tazemetostat)

Not yet recruiting
  • Follicular Lymphoma
  • (no location specified)
Dec 15, 2022

Follicular Lymphoma Trial in Boston (Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells)

Active, not recruiting
  • Follicular Lymphoma
  • Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Feb 28, 2022

Peripheral T-cell Lymphoma Targeted Therapy Trial in Tianjin (Azacitidine, Chidamide, Cyclophosphamide)

Enrolling by invitation
  • Peripheral T-cell Lymphoma Targeted Therapy
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Insititute & Hospital
Jan 9, 2023

Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, Ann Arbor Stage III Follicular Lymphoma Trial

Active, not recruiting
  • Ann Arbor Stage II Follicular Lymphoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 3, 2022

Lymphoma Trial in Norway, Sweden, Switzerland (Rituximab, lenalidomide)

Active, not recruiting
  • Lymphoma
  • Bergen, Norway
  • +32 more
Sep 27, 2022

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (Oral Azacitidine, Rituximab, cyclophosphamide)

Completed
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Follicular
  • Oral Azacitidine
  • +4 more
  • Tampa, Florida
  • +6 more
Aug 26, 2020